Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper.

Autor: Genazzani AR; Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, The University of Pisa, Pisa, Italy., Divakar H; Obstetrics and Gynaecology, Divakars Speciality Hospital, Bengaluru, India.; FIGO Committee on Well Woman Health Care, London, UK., Khadilkar SS; FIGO Committee on Well Woman Health Care, London, UK.; Department of Obstetrics and Gynecology, Bombay Hospital Institute of Medical Sciences, Mumbai, India., Monteleone P; Division of Obstetrics and Gynecology, Azienda USL Toscana Nord Ovest, Pisa, Italy., Evangelisti B; Department of Obstetrics and Gynecology, Sant'Anna University Hospital, Torino, Italy., Galal AF; FIGO Committee on Well Woman Health Care, London, UK.; Department of Obstetrics and Gynecology, Elshatby Maternity University Hospital, Alexandria, Egypt., Priego PIR; FIGO Committee on Well Woman Health Care, London, UK.; Hospital Ángeles del Pedregal, Mexico City, Mexico., Simoncini T; Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, The University of Pisa, Pisa, Italy., Giannini A; Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, The University of Pisa, Pisa, Italy., Goba G; FIGO Committee on Well Woman Health Care, London, UK.; Department of Obstetrics and Gynecology, University of Illinois, Chicago, Illinois, USA., Benedetto C; FIGO Committee on Well Woman Health Care, London, UK.; Department of Obstetrics and Gynecology, Sant'Anna University Hospital, Torino, Italy.
Jazyk: angličtina
Zdroj: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2024 Feb; Vol. 164 (2), pp. 516-530. Date of Electronic Publication: 2024 Jan 04.
DOI: 10.1002/ijgo.15278
Abstrakt: Menopause marks the end of menstrual cyclicity and, depending on individual vulnerability, has several consequences related to gonadal steroid deprivation, especially if it is premature. Menopause may be more burdensome for some women than for others. Individual factors, such as personal history, socioeconomic status, ethnicity, and current health conditions, affect symptomatology and, thereby, the menopausal experience. In addition, some menopausal symptoms, such as severe hot flashes, sleep disorders, and depression, are markers of future health risks. Counseling is a fundamental part of health care in the peri- and postmenopause periods. It must include an assessment of the patient's symptoms, needs, desires, and risk profile to address the benefits and risks of menopausal hormone therapy (MHT) on an individual basis and promote a healthy lifestyle. Indeed, healthcare practitioners can and must protect the health and lives of mid-life women by increasing awareness of menopausal symptoms and ensuring healthcare options, especially MHT. The type and duration of MHT should be tailored based on the patient's history, menopausal age, physical characteristics, and current health status so that the benefits always outweigh the risks. This FIGO position paper focuses on the benefits and risks of MHT on health domains, target organs, and systems, and on systemic and vaginal MHT regimens, to provide indications that can be used in the clinical practice for menopausal counseling. Moreover, it offers insights into what FIGO considers the mainstay for the healthcare management of women in peri- and postmenopause, worldwide.
(© 2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.)
Databáze: MEDLINE
Externí odkaz: